{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:03:57Z","timestamp":1766023437650,"version":"3.48.0"},"reference-count":40,"publisher":"e-Century Publishing Corporation","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/knyx4079","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T03:03:35Z","timestamp":1756955015000},"page":"3712-3727","source":"Crossref","is-referenced-by-count":0,"title":["Placental mesenchymal stem cell-derived interleukin-6 promotes neuroblastoma progression"],"prefix":"10.62347","volume":"15","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1016\/j.neuron.2022.07.012","article-title":"Neuroblastoma: when differentiation goes awry","volume":"110","author":"Zeineldin","year":"2022","unstructured":"Zeineldin M, Patel AG and Dyer MA. Neuroblastoma: when differentiation goes awry. Neuron 2022; 110: 2916-2928.","journal-title":"Neuron"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41588-023-01395-x","article-title":"Clonal evolution during metastatic spread in high-risk neuroblastoma","volume":"55","author":"Gundem","year":"2023","unstructured":"Gundem G, Levine MF, Roberts SS, Cheung IY, Medina-Martinez JS, Feng Y, Arango-Ossa JE, Chadoutaud L, Rita M, Asimomitis G, Zhou J, You D, Bouvier N, Spitzer B, Solit DB, Dela Cruz F, LaQuaglia MP, Kushner BH, Modak S, Shukla N, Iacobuzio-Donahue CA, Kung AL, Cheung NV and Papaemmanuil E. Clonal evolution during metastatic spread in high-risk neuroblastoma. Nat Genet 2023; 55: 1022-1033.","journal-title":"Nat Genet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"188805","DOI":"10.1016\/j.bbcan.2022.188805","article-title":"Tumoral heterogeneity in neuroblastoma","volume":"1877","author":"Gomez","year":"2022","unstructured":"Gomez RL, Ibragimova S, Ramachandran R, Philpott A and Ali FR. Tumoral heterogeneity in neuroblastoma. Biochim Biophys Acta Rev Cancer 2022; 1877: 188805.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Kennedy PT, Zannoupa D, Son MH, Dahal LN and Woolley JF. Neuroblastoma: an ongoing cold front for cancer immunotherapy. J Immunother Cancer 2023; 11: e007798.","DOI":"10.1136\/jitc-2023-007798"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00401-022-02484-7","article-title":"Jude Children’s Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials","volume":"144","author":"Liu","year":"2022","unstructured":"Liu APY, Dhanda SK, Lin T, Sioson E, Vasilyeva A, Gudenas B, Tatevossian RG, Jia S, Neale G, Bowers DC, Hassall T, Partap S, Crawford JR, Chintagumpala M, Bouffet E, McCowage G, Broniscer A, Qaddoumi I, Armstrong G, Wright KD, Upadhyaya SA, Vinitsky A, Tinkle CL, Lucas J, Chiang J, Indelicato DJ, Sanders R, Klimo P Jr, Boop FA, Merchant TE, Ellison DW, Northcott PA, Orr BA, Zhou X, Onar-Thomas A, Gajjar A and Robinson GW. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children’s Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials. Acta Neuropathol 2022; 144: 733-746.","journal-title":"Acta Neuropathol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s11912-022-01270-8","article-title":"Neuroblastoma heterogeneity, plasticity, and emerging therapies","volume":"24","author":"KI","year":"2022","unstructured":"Lundberg KI, Treis D and Johnsen JI. Neuroblastoma heterogeneity, plasticity, and emerging therapies. Curr Oncol Rep 2022; 24: 1053-1062.","journal-title":"Curr Oncol Rep"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"7730","DOI":"10.3390\/ijms25147730","article-title":"Neuroblastoma-a review of combination immunotherapy","volume":"25","author":"Pieniazek","year":"2024","unstructured":"Pieniazek B, Cencelewicz K, Bzdziuch P, Mlynarczyk L, Lejman M, Zawitkowska J and Derwich K. Neuroblastoma-a review of combination immunotherapy. Int J Mol Sci 2024; 25: 7730.","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.soc.2020.11.010","article-title":"Management of neuroblastoma in pediatric patients","volume":"30","author":"Croteau","year":"2021","unstructured":"Croteau N, Nuchtern J and LaQuaglia MP. Management of neuroblastoma in pediatric patients. Surg Oncol Clin N Am 2021; 30: 291-304.","journal-title":"Surg Oncol Clin N Am"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/08880018.2017.1330375","article-title":"Neuroblastoma in children: update on clinicopathologic and genetic prognostic factors","volume":"34","author":"Ahmed","year":"2017","unstructured":"Ahmed AA, Zhang L, Reddivalla N and Hetherington M. Neuroblastoma in children: update on clinicopathologic and genetic prognostic factors. Pediatr Hematol Oncol 2017; 34: 165-185.","journal-title":"Pediatr Hematol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13045-021-01208-w","article-title":"Mesenchymal stem\/stromal cells in cancer therapy","volume":"14","author":"Lan","year":"2021","unstructured":"Lan T, Luo M and Wei X. Mesenchymal stem\/stromal cells in cancer therapy. J Hematol Oncol 2021; 14: 195.","journal-title":"J Hematol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.2174\/1567201817999200819140912","article-title":"Mesenchymal stem cells mediated drug delivery in tumor-targeted therapy","volume":"18","author":"Xie","year":"2021","unstructured":"Xie M, Tao L, Zhang Z and Wang W. Mesenchymal stem cells mediated drug delivery in tumor-targeted therapy. Curr Drug Deliv 2021; 18: 876-891.","journal-title":"Curr Drug Deliv"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s13287-021-02562-9","article-title":"The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor","volume":"12","author":"Becerril-Rico","year":"2021","unstructured":"Becerril-Rico J, Alvarado-Ortiz E, Toledo-Guzman ME, Pelayo R and Ortiz-Sanchez E. The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor. Stem Cell Res Ther 2021; 12: 498.","journal-title":"Stem Cell Res Ther"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"110121","DOI":"10.1016\/j.intimp.2023.110121","article-title":"Hsa_circ_0073453 modulates IL-8 secretion by GC-MSCs to promote gastric cancer progression by sponging miR-146a-5p","volume":"119","author":"Wu","year":"2023","unstructured":"Wu C, Cao X, Xu J, Wang L, Huang J, Wen J, Wang X, Sang X, Zhu W, Yao Y, Zhou C, Huang F and Wang M. Hsa_circ_0073453 modulates IL-8 secretion by GC-MSCs to promote gastric cancer progression by sponging miR-146a-5p. Int Immunopharmacol 2023; 119: 110121.","journal-title":"Int Immunopharmacol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2174\/1574888X15666201022111942","article-title":"The Role of cytokines in interactions of mesenchymal stem cells and breast cancer cells","volume":"16","author":"Jayaraman","year":"2021","unstructured":"Jayaraman H, Ghone NV, Rajan RK and Dashora H. The Role of cytokines in interactions of mesenchymal stem cells and breast cancer cells. Curr Stem Cell Res Ther 2021; 16: 443-453.","journal-title":"Curr Stem Cell Res Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s13287-020-01849-7","article-title":"The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm","volume":"11","author":"Kavianpour","year":"2020","unstructured":"Kavianpour M, Saleh M and Verdi J. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm. Stem Cell Res Ther 2020; 11: 404.","journal-title":"Stem Cell Res Ther"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13045-021-01141-y","article-title":"Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer","volume":"14","author":"Weng","year":"2021","unstructured":"Weng Z, Zhang B, Wu C, Yu F, Han B, Li B and Li L. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J Hematol Oncol 2021; 14: 136.","journal-title":"J Hematol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/cgt.2014.19","article-title":"Human placenta mesenchymal stem cells expressing exogenous kringle1-5 protein by fiber-modified adenovirus suppress angiogenesis","volume":"21","author":"Chu","year":"2014","unstructured":"Chu Y, Liu H, Lou G, Zhang Q and Wu C. Human placenta mesenchymal stem cells expressing exogenous kringle1-5 protein by fiber-modified adenovirus suppress angiogenesis. Cancer Gene Ther 2014; 21: 200-208.","journal-title":"Cancer Gene Ther"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","unstructured":"Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol 2021; 33: 127-148.","journal-title":"Int Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1038\/s41388-024-03183-1","article-title":"Mesenchymal stromal cells as cancer promoters","volume":"43","author":"Antoon","year":"2024","unstructured":"Antoon R, Overdevest N, Saleh AH and Keating A. Mesenchymal stromal cells as cancer promoters. Oncogene 2024; 43: 3545-3555.","journal-title":"Oncogene"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nm.2379","article-title":"Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs","volume":"17","author":"Oskarsson","year":"2011","unstructured":"Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, Downey RJ, Manova-Todorova K, Brogi E and Massague J. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 2011; 17: 867-874.","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Pelekanos RA, Sardesai VS, Futrega K, Lott WB, Kuhn M and Doran MR. Isolation and expansion of mesenchymal stem\/stromal cells derived from human placenta tissue. J Vis Exp 2016; 54204.","DOI":"10.3791\/54204-v"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.canlet.2005.11.007","article-title":"Inhibition of transforming growth factor-beta\/Smad signaling by phosphatidylinositol 3-kinase pathway","volume":"242","author":"Qiao","year":"2006","unstructured":"Qiao J, Kang J, Ko TC, Evers BM and Chung DH. Inhibition of transforming growth factor-beta\/Smad signaling by phosphatidylinositol 3-kinase pathway. Cancer Lett 2006; 242: 207-214.","journal-title":"Cancer Lett"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.7150\/ijbs.28050","article-title":"Nitric oxide prevents H(2)O(2)-induced apoptosis in SK-N-MC human neuroblastoma cells","volume":"14","author":"Yoo","year":"2018","unstructured":"Yoo YM, Jung EM, Ahn C and Jeung EB. Nitric oxide prevents H(2)O(2)-induced apoptosis in SK-N-MC human neuroblastoma cells. Int J Biol Sci 2018; 14: 1974-1984.","journal-title":"Int J Biol Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41419-017-0060-1","article-title":"Cell death-based treatment of neuroblastoma","volume":"9","author":"Valter","year":"2018","unstructured":"Valter K, Zhivotovsky B and Gogvadze V. Cell death-based treatment of neuroblastoma. Cell Death Dis 2018; 9: 113.","journal-title":"Cell Death Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1039\/D4LC00005F","article-title":"Diagnostic technologies for neuroblastoma","volume":"25","author":"Khelifa","year":"2025","unstructured":"Khelifa L, Hu Y, Tall J, Khelifa R, Ali A, Poon E, Khelifa MZ, Yang G, Jones C, Moreddu R, Jiang N, Tasoglu S, Chesler L and Yetisen AK. Diagnostic technologies for neuroblastoma. Lab Chip 2025; 25: 3630-3664.","journal-title":"Lab Chip"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1200\/JCO.21.00278","article-title":"Revised neuroblastoma risk classification system: a report from the Children’s Oncology Group","volume":"39","author":"Irwin","year":"2021","unstructured":"Irwin MS, Naranjo A, Zhang FF, Cohn SL, London WB, Gastier-Foster JM, Ramirez NC, Pfau R, Reshmi S, Wagner E, Nuchtern J, Asgharzadeh S, Shimada H, Maris JM, Bagatell R, Park JR and Hogarty MD. Revised neuroblastoma risk classification system: a report from the Children’s Oncology Group. J Clin Oncol 2021; 39: 3229-3241.","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"114551","DOI":"10.1016\/j.celrep.2024.114551","article-title":"Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transfer","volume":"43","author":"Frisbie","year":"2024","unstructured":"Frisbie L, Pressimone C, Dyer E, Baruwal R, Garcia G, St Croix C, Watkins S, Calderone M, Gorecki G, Javed Z, Atiya HI, Hempel N, Pearson A and Coffman LG. Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transfer. Cell Rep 2024; 43: 114551.","journal-title":"Cell Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2174\/1574888X18666221124145847","article-title":"Gastric cancer derived mesenchymal stem cells promote the migration of gastric cancer cells through miR-374a-5p","volume":"18","author":"Ji","year":"2023","unstructured":"Ji R, Lin J, Gu H, Ma J, Fu M and Zhang X. Gastric cancer derived mesenchymal stem cells promote the migration of gastric cancer cells through miR-374a-5p. Curr Stem Cell Res Ther 2023; 18: 853-863.","journal-title":"Curr Stem Cell Res Ther"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.semcancer.2022.09.002","article-title":"Mesenchymal stem\/stromal cells in breast cancer development and management","volume":"86","author":"Tu","year":"2022","unstructured":"Tu Z and Karnoub AE. Mesenchymal stem\/stromal cells in breast cancer development and management. Semin Cancer Biol 2022; 86: 81-92.","journal-title":"Semin Cancer Biol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13287-022-02906-z","article-title":"Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt\/beta-catenin signaling pathway in mice","volume":"13","author":"Liu","year":"2022","unstructured":"Liu QW, Ying YM, Zhou JX, Zhang WJ, Liu ZX, Jia BB, Gu HC, Zhao CY, Guan XH, Deng KY and Xin HB. Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt\/beta-catenin signaling pathway in mice. Stem Cell Res Ther 2022; 13: 224.","journal-title":"Stem Cell Res Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"101739","DOI":"10.1016\/j.bbrep.2024.101739","article-title":"Distinct biological characteristics of mesenchymal stem cells separated from different components of human placenta","volume":"39","author":"Deng","year":"2024","unstructured":"Deng X, Zhang S, Qing Q, Wang P, Ma H, Ma Q, Zhao W, Tang H and Lu M. Distinct biological characteristics of mesenchymal stem cells separated from different components of human placenta. Biochem Biophys Rep 2024; 39: 101739.","journal-title":"Biochem Biophys Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s12272-009-2106-0","article-title":"Snake venom toxin inhibits cell growth through induction of apoptosis in neuroblastoma cells","volume":"32","author":"Park","year":"2009","unstructured":"Park MH, Son DJ, Kwak DH, Song HS, Oh KW, Yoo HS, Lee YM, Song MJ and Hong JT. Snake venom toxin inhibits cell growth through induction of apoptosis in neuroblastoma cells. Arch Pharm Res 2009; 32: 1545-1554.","journal-title":"Arch Pharm Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/cancers13030529","article-title":"Association of genetic polymorphisms and serum levels of IL-6 and IL-8 with the prognosis in children with neuroblastoma","volume":"13","author":"Moreno-Guerrero","year":"2021","unstructured":"Moreno-Guerrero SS, Ramirez-Pacheco A, Rocha-Ramirez LM, Hernandez-Pliego G, Eguia-Aguilar P, Escobar-Sanchez MA, Reyes-Lopez A, Juarez-Villegas LE and Sienra-Monge JJL. Association of genetic polymorphisms and serum levels of IL-6 and IL-8 with the prognosis in children with neuroblastoma. Cancers (Basel) 2021; 13: 529.","journal-title":"Cancers (Basel)"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Siersbaek R, Scabia V, Nagarajan S, Chernukhin I, Papachristou EK, Broome R, Johnston SJ, Joosten SEP, Green AR, Kumar S, Jones J, Omarjee S, Alvarez-Fernandez R, Glont S, Aitken SJ, Kishore K, Cheeseman D, Rakha EA, D’Santos C, Zwart W, Russell A, Brisken C and Carroll JS. IL6\/STAT3 signaling hijacks estrogen receptor alpha enhancers to drive breast cancer metastasis. Cancer Cell 2020; 38: 412-423, e9.","DOI":"10.1016\/j.ccell.2020.06.007"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12885-024-12120-0","article-title":"ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells","volume":"24","author":"Lin","year":"2024","unstructured":"Lin T, Zhang S, Tang Y, Xiao M, Li M, Gong H, Xie H and Wang Y. ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells. BMC Cancer 2024; 24: 354.","journal-title":"BMC Cancer"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1010428317705748","DOI":"10.1177\/1010428317705748","article-title":"Endoplasmic reticulum stress could induce autophagy and apoptosis and enhance chemotherapy sensitivity in human esophageal cancer EC9706 cells by mediating PI3K\/Akt\/mTOR signaling pathway","volume":"39","author":"Zhou","year":"2017","unstructured":"Zhou F, Li YH, Wang JJ, Pan J and Lu H. Endoplasmic reticulum stress could induce autophagy and apoptosis and enhance chemotherapy sensitivity in human esophageal cancer EC9706 cells by mediating PI3K\/Akt\/mTOR signaling pathway. Tumour Biol 2017; 39: 1010428317705748.","journal-title":"Tumour Biol"},{"key":"ref36","unstructured":"Ouyang J, Pan X, Lin H, Hu Z, Xiao P and Hu H. GKN2 increases apoptosis, reduces the proliferation and invasion ability of gastric cancer cells through down-regulating the JAK\/STAT signaling pathway. Am J Transl Res 2017; 9: 803-811."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2147\/DDDT.S132488","article-title":"Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2\/STAT3 and PI3K\/Akt\/NFkappaB pathways in cholangiocarcinoma cells","volume":"11","author":"Ke","year":"2017","unstructured":"Ke F, Wang Z, Song X, Ma Q, Hu Y, Jiang L, Zhang Y, Liu Y, Zhang Y and Gong W. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2\/STAT3 and PI3K\/Akt\/NFkappaB pathways in cholangiocarcinoma cells. Drug Des Devel Ther 2017; 11: 1753-1766.","journal-title":"Drug Des Devel Ther"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11010-020-03813-8","article-title":"Speedy\/RINGO protein interacts with ERK\/MAPK and PI3K\/AKT pathways in SH-SY5Y neuroblastoma cells","volume":"473","author":"Kaya","year":"2020","unstructured":"Kaya Y, Kucukvardar S and Yildiz A. Speedy\/RINGO protein interacts with ERK\/MAPK and PI3K\/AKT pathways in SH-SY5Y neuroblastoma cells. Mol Cell Biochem 2020; 473: 133-141.","journal-title":"Mol Cell Biochem"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3892\/ol.2020.11913","article-title":"Apatinib induces apoptosis and autophagy via the PI3K\/AKT\/mTOR and MAPK\/ERK signaling pathways in neuroblastoma","volume":"20","author":"Yu","year":"2020","unstructured":"Yu X, Fan H, Jiang X, Zheng W, Yang Y, Jin M, Ma X and Jiang W. Apatinib induces apoptosis and autophagy via the PI3K\/AKT\/mTOR and MAPK\/ERK signaling pathways in neuroblastoma. Oncol Lett 2020; 20: 52.","journal-title":"Oncol Lett"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/8\/ajcr0166047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:59:07Z","timestamp":1766023147000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/8\/ajcr0166047.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/knyx4079","relation":{},"ISSN":["2156-6976"],"issn-type":[{"type":"electronic","value":"2156-6976"}],"subject":[],"published":{"date-parts":[[2025]]}}}